Skip to content

Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means

Addressing Heightened Levels of Aggression in Traumatized Offenders With Psychotherapeutic Means: A Randomized Controlled Trial in Eastern DR Congo

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02992561
Enrollment
402
Registered
2016-12-14
Start date
2016-09-30
Completion date
2019-03-31
Last updated
2020-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appetitive Aggression

Keywords

Aggression, Violence, Post-conflict reconstruction, Demobilization, Traumatized offenders

Brief summary

Heightened levels of aggression are fuelling violent incidents at all levels, especially in post-war regions. Narrative Exposure Therapy for Forensic Offender Rehabilitation (FORNET) aims to address trauma symptoms along with reactive and instrumental/appetitive aggression to encounter the downward cycle of perpetration and enforce a sustainable (re-)integration into civil life. In the present study, the investigators provide an adapted version of FORNET to former combatants in the North Kivu, Eastern DR Congo. Structured baseline, 3 and 6 month follow up interviews will be administered to assess the main outcome measures recent violent acts and appetitive aggression.

Detailed description

Participants will be recruited through local NGOs and eligible clients randomized to the treatment or waitlist control group, respectively. The treatment will be provided by supervised local counsellors after a 4-week training. At baseline, 3-month and 6-month follow up, sociodemographic data, trauma exposure, perpetrated violent acts, PTSD, recent aggression, functionality and drug dependency will be assessed. The interviews will be conducted by blind Congolese psychological interviewers after an intensive 3-weeks training and continuous supervision.

Interventions

BEHAVIORALFORNET (adapted version)

Sponsors

University of Konstanz
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

Eligibility criteria * Former participant of an armed group in DR Congo * Involvement in violent attacks Inclusion Criteria: * PTSD diagnosis or AAS sum score of 22 or higher

Exclusion criteria

* Acute intoxification (alcohol or other drugs) * Acute psychotic symptoms * Sign of cerebro-organic diseases

Design outcomes

Primary

MeasureTime frameDescription
Appetitive aggression (sumscore; 0-60 indicating higher levels)Change from baseline to 3-5 and 6-9 months post treatmentAppetitive Aggression Scale (Weierstall & Ebert, 2011)
Current violent behavior (sumscore; 0-96 indicating more acts)Change from baseline to 3-5 and 6-9 months post treatmentA list of violent offenses perpetrated during the last 3 months (formerly used in Burundi; Crombach/Augsburger/Nandi)

Secondary

MeasureTime frameDescription
PSS-I: Posttraumatic Stress Disorder (sumscore, 0-80 indicating higher severity)Change from baseline to 3-5 and 6-9 months post treatmentPTSD Symptom Scale (Foa & Tolin, 2000)

Other

MeasureTime frameDescription
Social acknowledgement (0-45 indicating more social acknowledgment)Change from baseline to 3-5 and 6-9 months post treatmentSocial Acknowledgement Questionnaire (Maerker & Mueller, 2004)
Epigenetic changesChange from baseline to 6-9 month post treatmentGenome wide methylation patterns (to be explored)
Depression (0-27 indicating higher severity)Change from baseline to 3-5 and 6-9 months post treatmentPatient Health Questionnaire - 9 (Kroenke & Spitzer, 2002)
Substance use problemsChange from baseline to 3-5 and 6-9 months post treatmentAlcohol, Smoking and Substance Involvement Screening Test (Humeniuk et al., 2008)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 21, 2026